Hoth Therapeutics Inc. logo

Hoth Therapeutics Inc. (HOTH)

Market Open
12 Jun, 15:18
NASDAQ (CM) NASDAQ (CM)
$
1. 41
-0.07
-4.7297%
$
28.37M Market Cap
- P/E Ratio
- Div Yield
9.22M Volume
-1.81 Eps
$ 1.48
Previous Close
Investors:
Add Transaction
Day Range
1.34 1.71
Year Range
0.49 2.45
Want to track HOTH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Hoth Therapeutics Inc. logo
HOTH Hoth Therapeutics Inc.
3 Jun 2026
-
-
Hoth Therapeutics Inc. logo
HOTH Hoth Therapeutics Inc.
11 May 2026
-
-
Hoth Therapeutics Inc. logo
HOTH Hoth Therapeutics Inc.
27 Mar 2026
-
-
Hoth Therapeutics Inc. logo
HOTH Hoth Therapeutics Inc.
3 Dec 2025
-
-
Hoth Therapeutics Inc. logo
HOTH Hoth Therapeutics Inc.
11 Nov 2025
-
-
Hoth Therapeutics Inc. logo
HOTH Hoth Therapeutics Inc.
8 Aug 2025
-
-
Hoth Therapeutics Inc. logo
HOTH Hoth Therapeutics Inc.
12 May 2025
-
-
Hoth Therapeutics Inc. logo
HOTH Hoth Therapeutics Inc.
26 Mar 2025
-
-
Hoth Therapeutics Inc. logo
HOTH Hoth Therapeutics Inc.
11 Nov 2024
-
-
Hoth Therapeutics Inc. logo
HOTH Hoth Therapeutics Inc.
9 Aug 2024
-
-
Hoth Therapeutics Inc. logo
HOTH Hoth Therapeutics Inc.
15 May 2024
-
-
Hoth Therapeutics Inc. logo
HOTH Hoth Therapeutics Inc.
31 Mar 2024
-
-
Hoth Therapeutics Inc. logo
HOTH Hoth Therapeutics Inc.
10 Nov 2023
-
-

HOTH Earnings Reports FAQ

What is the earnings per share (EPS) for HOTH?

The current EPS is -1.81.

What is the company's earnings growth rate?

Hoth Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Hoth Therapeutics Inc has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Hoth Therapeutics Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for HOTH at this time, as Hoth Therapeutics Inc has no recent EPS data to calculate it.